Total Funding
63
68
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
76386
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
- Praful Doshi: Founder, President, CTO
- Dan Myers: Chief Executive OfficerPast Role: Alimera Sciences, President, Founder & CEO
About the Company
MediPrint Ophthalmics (formerly Leo Lens Pharma) is an emerging San Diego-based clinical stage eye care pharmaceutical company focused on helping protect sight by developing and commercializing a proprietary ocular drug delivery portfolio.
The company was founded in 2001 and is based in San Diego, California, United States.
